论文部分内容阅读
新一轮的医改又出大招。近日,国家卫计委官网发布了《关于进一步改革完善药品生产流通使用政策的若干意见》,文件涉及了药品生产、流通、使用、销售的全部环节,直面医药领域最突出的问题,开出药品改革的“中国药方”。《意见》总共是17条,一经发布后,国内医药圈瞬间就被刷屏了,尤其第15条,更是引人关注并引发热议。“鼓励到零售药店购药等改革,门诊患者可以自主选择在医疗机构或零售药店购药,医疗机构不得限制门诊患者凭处方到零售药店购药。具备条件的可探索将门诊药房从医疗机构剥
A new round of medical reform and a big move. Recently, the State Health Planning Commission’s official website promulgated the ”Several Opinions on Further Reforming and Perfecting the Policy on the Production, Distribution and Use of Medicines“, covering all aspects of the production, distribution, use and sale of pharmaceutical products, facing the most prominent problems in the field of medicine and opening up medicines Reform ”Chinese prescription “. The ”Opinions“ totaled 17, and once released, the domestic medical circle was momentarily scrubbed. In particular, Article 15 attracted even more attention and sparked heated debate. ”To encourage the reform of the retail pharmacies to buy medicine, outpatient patients can choose to purchase medicine at medical institutions or retail pharmacies, medical institutions shall not restrict outpatient patients with prescriptions to the retail pharmacies to buy medicine. Have the conditions to explore out-patient pharmacies from the medical institutions peel